Patents by Inventor Jim Li

Jim Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190315733
    Abstract: The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
    Type: Application
    Filed: May 3, 2019
    Publication date: October 17, 2019
    Inventors: Jim Li, Lijing Chen, Bindu Goyal, Guy Laidig, Timothy F. Stanton, Eric B. Sjogren
  • Publication number: 20190310354
    Abstract: Embodiments discussed herein refer to LiDAR systems that use avalanche photo diodes for detecting returns of laser pulses. The bias voltage applied to the avalanche photo diode is adjusted to ensure that it operates at desired operating capacity.
    Type: Application
    Filed: April 9, 2019
    Publication date: October 10, 2019
    Inventors: Yufeng Li, Yimin Li, Rui Zhang, Junwei Bao, Jim Li
  • Publication number: 20190265334
    Abstract: In accordance with some embodiments, a light detection and ranging (LiDAR) system comprise: a control system housing; a first LiDAR head housing separate and distinct from the control system housing; a light source within the control system housing configured to produce a first pulse signal; a light detector within the control system housing configured to detect a first return pulse signal associated with the pulse signal; a first pulse steering system within the first LiDAR housing configured to direct the first pulse signal in a first direction; a first fiber coupled to the light source and the first pulse steering system, the first fiber configured to carry the first pulse signal from the light source to the first pulse steering system; and a second fiber configured to carry a first returned pulse signal from the first LiDAR head housing to the light detector.
    Type: Application
    Filed: February 21, 2019
    Publication date: August 29, 2019
    Inventors: Rui ZHANG, Jim LI, Yufeng LI, Yimin LI, Junwei BAO
  • Publication number: 20190265339
    Abstract: In accordance with some embodiments, a light detection and ranging (LiDAR) system comprises: a control system housing; a first LiDAR head housing separate and distinct from the control system housing; a light source within the control system housing, the light source configured to produce a first pulse signal; a light detector within the control system housing configured to detect a first return pulse signal associated with the pulse signal; a first pulse steering system within the first LiDAR head housing, the first pulse steering system configured to direct the first pulse signal in a first direction; a first fiber configured to carry the first pulse signal from the light source to the first pulse steering system; and a second fiber configured to carry a first returned pulse signal from the first LiDAR head housing to the light detector.
    Type: Application
    Filed: February 21, 2019
    Publication date: August 29, 2019
    Inventors: Rui ZHANG, Jim LI, Yufeng LI, Yimin LI, Junwei BAO
  • Patent number: 10397325
    Abstract: A self-describing data format capable of carrying payload information, such as Tuxedo payload information, as well as filter information. The data format can allow for expression of some or all of Tuxedo Typed Buffers, including STRING, CARRAY, MBSTRING, VIEW, VIEW32, FML, and FML32. The data format is also capable of supporting nesting and error-checking. The proposal of user payload collection can allow customers to siphon off user/payload data to be used in applications, such as Business Intelligence applications, without the need for additional information to be passed with the payload data.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: August 27, 2019
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: Hui Chen, Todd Little, Xiangdong Li, Jim Yongshun Jin
  • Publication number: 20190257924
    Abstract: In accordance with some embodiments, a light detection and ranging (LiDAR) system comprises: a light source configured to generate a pulse signal from the LiDAR system; one or more mirrors configured to steer a returned light pulse associated with the transmitted pulse signal along an optical receive path; a field lens positioned along the optical receive path, wherein the field lens is configured to redirect the returned light pulse; a fiber having a receiving end configured to receive the returned light pulse from the field lens along the optical receive path; and a light detector configured to receive the returned light pulse from an end of the fiber opposite the receiving end.
    Type: Application
    Filed: February 22, 2019
    Publication date: August 22, 2019
    Inventors: Jim LI, Yimin LI, Junwei BAO
  • Publication number: 20190252863
    Abstract: Apparatus include a first laser diode situated to emit a beam from an exit facet along an optical axis, the beam as emitted having perpendicular fast and slow axes perpendicular to the optical axis, a first fast axis collimator (FAC) optically coupled to the beam as emitted from the exit facet and configured to direct the beam along a redirected beam axis having a non-zero angle with respect to the optical axis of the first laser diode, a second laser diode situated to emit a beam from an exit facet of the second laser diode along an optical axis parallel to the optical axis of the first laser diode and with a slow axis in a common plane with the slow axis of the first laser diode, and a second fast axis collimator (FAC) optically coupled to the beam as emitted from the exit facet of the second laser diode and configured to direct the beam along a redirected beam axis having a non-zero angle with respect to the optical axis of the second laser diode.
    Type: Application
    Filed: February 6, 2019
    Publication date: August 15, 2019
    Applicant: nLIGHT, Inc.
    Inventors: Zhigang Chen, Manoj Kanskar, Shuang Li, Jim Zhang, Mark DeFranza, David Martin Hemenway, Eric Martin, Jay Small
  • Patent number: 10367596
    Abstract: A multiple wavelength selective switch has an optics assembly to receive a first input optical signal from a first ingress port and a second input optical signal from a second ingress port. A switch assembly has a single switching mechanism to direct the first input optical signal to the optics assembly as a first output optical signal and the second input optical signal to the optics assembly as a second output optical signal. The switch assembly directs the first output optical signal to a first egress port selected from the first set of egress ports and directs the second output optical signal to a second egress port selected from the second set egress ports. The first egress port and the second egress port have the same wavelength channel. The multiple wavelength selective switch supports an arbitrary number of wavelength channels that can be switched at the same time. Each switch assembly directs signals from a set of ingress ports to a set of egress ports sharing the same wavelength channel.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: July 30, 2019
    Assignee: II-VI Delaware, Inc.
    Inventors: Oliver Lu, Helen Chen, Gordon Jiang, Simon He, Lawrence Wang, Tom Li, Jim Yuan, Jack Kelly, Fenghua Li
  • Patent number: 10355959
    Abstract: Examples are disclosed for determining or using server transaction latency information. In some examples, a network input/output device coupled to a server may be capable of time stamping information related to ingress request and egress response packets for a transaction. For these examples, elements of the server may be capable of determining transaction latency values based on the time stamped information. The determined transaction latency values may be used to monitor or manage operating characteristics of the server to include an amount of power provided to the server or an ability of the server to support one or more virtual servers. Other examples are described and claimed.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: July 16, 2019
    Assignee: INTEL CORPORATION
    Inventors: Manasi Deval, Jim Daubert, Eric K. Mann, Cong Li, Muralidhar Murali Rajappa, Anjaneya Reddy Chagam Reddy, David Wescott, Ramkumar Nagappan, Raed Kanjo
  • Publication number: 20190190610
    Abstract: One example includes a bias-based Mach-Zehnder modulation (MZM) system. The system includes a Mach-Zehnder modulator to receive and split an optical input signal and to provide an intensity-modulated optical output signal based on a high-frequency data signal to modulate a relative phase of the split optical input signal to transmit data and based on a bias voltage to modulate the relative phase of the split optical input signal to tune the Mach-Zehnder modulator. The system also includes a bias feedback controller to compare a detection voltage associated with the intensity-modulated output signal with a reference voltage to measure an extinction ratio associated with an optical power of the intensity-modulated optical output signal and to adjust the bias voltage based on the comparison to substantially maximize the extinction ratio.
    Type: Application
    Filed: February 14, 2019
    Publication date: June 20, 2019
    Inventors: Cheng Li, Jim Huang, Ashkan Seyedi, Marco Fiorentino, Raymond G. Beausoleil
  • Patent number: 10301348
    Abstract: Compounds for use in prevention and treatment of neurodegenerative disease and pain are disclosed. In one embodiment of the invention, the compound is selected from the group consisting of N6-[(3-halothien-2-yl)methyl]adenosine, N6-[(4-halothien-2-yl)methyl]adenosine, and N6-[(5-halothien-2-yl)methyl]adenosine. In another embodiment of the invention, the compound is selected from the group consisting of N6-[(2-bromothien-3-yl)methyl]adenosine, N6-[(4-bromothien-3-yl)methyl]adenosine, N6-[(5-bromothien-3-yl)methyl]adenosine N6-[(2-chlorothien-3-yl)methyl]adenosine, N6-[(4-chlorothien-3-yl)methyl]adenosine, and N6-[(5-chlorothien-3-yl)methyl]adenosine. Also disclosed are methods of making and using the same.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: May 28, 2019
    Assignee: ACADEMIA SINICA
    Inventors: Jim-Min Fang, Yun-Lian Lin, Jung-Hsin Lin, Chun-Jung Lin, Yijuang Chern, Nai-Kuei Huang, Hung-Li Wang, Benjamin Pang-hsien Tu, Chih-Cheng Chen
  • Patent number: 10287303
    Abstract: The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: May 14, 2019
    Assignee: Calithera Biosciences, Inc.
    Inventors: Eric B. Sjogren, Jim Li, Lijing Chen, Roland J. Billedeau, Timothy F. Stanton, Michael Van Zandt, Darren Whitehouse, Gunnar E. Jagdmann, Jr., Lene Raunkjær Petersen
  • Publication number: 20180346489
    Abstract: The invention relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the invention. Also provided herein are methods of treating cancer with the arginase inhibitors of the invention.
    Type: Application
    Filed: August 10, 2018
    Publication date: December 6, 2018
    Inventors: Eric B. SJOGREN, Jim LI, Michael VAN ZANDT, Darren WHITEHOUSE
  • Patent number: 10065974
    Abstract: The invention relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the invention. Also provided herein are methods of treating cancer with the arginase inhibitors of the invention.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: September 4, 2018
    Inventors: Eric B. Sjogren, Jim Li, Michael Van Zandt, Darren Whitehouse
  • Publication number: 20180222926
    Abstract: The disclosure relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the disclosure. Also provided herein are methods of treating cancer with the arginase inhibitors of the disclosure.
    Type: Application
    Filed: December 22, 2017
    Publication date: August 9, 2018
    Inventors: Eric B. SJOGREN, Jim LI, Lijing CHEN, Roland J. BILLEDEAU, Timothy F. STANTON, Michael VAN ZANDT, Darren WHITEHOUSE, Gunnar E. JAGDMANN, Jr, Lene Raunkjaer PETERSEN, Francesco PARLATI, Matthew I. GROSS
  • Publication number: 20180186827
    Abstract: The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.
    Type: Application
    Filed: December 21, 2017
    Publication date: July 5, 2018
    Inventors: Roland J. Billedeau, Jim Li, Lijing Chen
  • Patent number: 9938267
    Abstract: The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: April 10, 2018
    Assignee: Calithera Biosciences, Inc.
    Inventors: Jim Li, Lijing Chen, Bindu Goyal, Guy Laidig, Timothy F. Stanton, Eric B. Sjogren
  • Publication number: 20180072742
    Abstract: The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 15, 2018
    Inventors: Lijing Chen, Jim Li, Eric B. Sjogren, Roland J. Billedeau
  • Publication number: 20170369485
    Abstract: The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
    Type: Application
    Filed: September 11, 2017
    Publication date: December 28, 2017
    Inventors: Jim Li, Lijing Chen, Bindu Goyal, Guy Laidig, Timothy F. Stanton, Eric B. Sjogren
  • Publication number: 20170354526
    Abstract: There is provided an orthotic configured for muscle imbalance correction. The orthotic has a strapping configured for physically activating an undercompensating muscle group by physically pulling substantially in-line with muscle fibres of the undercompensating muscle group to assist muscle activation and physically deactivating an overcompensating muscle group by physically pulling and therefore compressing across muscle fibres of the overcompensating muscle group to provide muscle resistance. Examples of the undercompensating muscle group are at least one of the gluteus maximus, medius, and minimus, vastus medialis and vastus medialis oblique. Examples of the overcompensating muscle group are at least one of the tensor fascia latae and iliopsoas.
    Type: Application
    Filed: January 19, 2016
    Publication date: December 14, 2017
    Inventor: Jim Li